Literature DB >> 6135577

Characterization of diaminouracil metabolites of caffeine in human urine.

A R Branfman, M F McComish, R J Bruni, M M Callahan, R Robertson, D W Yesair.   

Abstract

A major caffeine metabolite (A1) has been isolated from human urine by a combination of solvent extraction, reverse phase high-pressure liquid chromatography, and silica gel open column chromatography. The chromatographic and spectral properties of A1 are identical with an authentic sample of 5-acetylamino-6-amino-3-methyluracil. A stable isotope-labeling study, in which [2-14C]caffeine in a 1:1 mixture of unlabeled caffeine and [1,3-15N-8-13C] caffeine was administered to subjects, demonstrated that the C-8 carbon of caffeine was lost during the biotransformation to A1. Thus, the acetyl group in A1 does not originate from caffeine. The 1:1 ratio of the mass spectral ions for A1 isolated from the stable isotope study and the specific activity of A1 support caffeine as the principal source of A1. A related metabolite (A2) was too labile for complete purification and structural identification. The chromatographic and mass spectral properties of the degradation product of A2 were identical with those of A1.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135577

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  3 in total

1.  Urinary metabolites of caffeine in the premature infant.

Authors:  R Gorodischer; E Zmora; Z Ben-Zvi; D Warszwaski; A Yaari; S Sofer; M J Arnaud
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  A statistical procedure to selectively detect metabolite signals in LC-MS data based on using variable isotope ratios.

Authors:  Lung-Cheng Lin; Hsin-Yi Wu; Vincent Shin-Mu Tseng; Lien-Chin Chen; Yu-Chen Chang; Pao-Chi Liao
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-12       Impact factor: 3.109

3.  The acetylator phenotypes of Saudi Arabian diabetics.

Authors:  D A Evans; S Paterson; P Francisco; G Alvarez
Journal:  J Med Genet       Date:  1985-12       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.